Print This Page


November 25 2015

United States

Washington DC—FDA Won’t Target Shrimp in 2016

 

FDA has announced more information about a new intensive sampling program it will undertake as part of the new food safety and modernization act.

 

The sampling is to implement a risk-based preventive approach and to give the FDA data on imported foods that are potential sources of illness.

 

Shrimp is not considered a high-risk food by the FDA.  Despite the lobbying of some domestic shrimp producers, there has been no evidence of any human disease caused by imported shrimp.

 

In their microbiological sampling program, the FDA is targeting foods that potentially contain E. coli, Salmonella or Listeria monocytogenes.

 

FDA’s sampling of shrimp has been targeted at illegal use of veterinary antibiotics, not at microbiological contamination.  This is because shrimp is not a foodstuff that has led to reported illness in the USA.  The focus on intensive microbiological testing suggests that the FDA will continue to focus its intensive sampling program on high-risk foods that have a documented record of causing illness.

 

Source: Seafood.com (an online, subscription-based, fisheries news service).  Editor and Publisher, John Sackton (phone 1-781-861-1441, email jsackton@seafood.com).  FDA to Do Intensive Sampling of High Risk Food Commodities; Does Not Plan to Target Shrimp in 2016.  John Sackton.  November 24, 2015.

Print This Page